ADVFN - Advanced Financial Network.
HOME» NYSE » O » OCR Stock Price » OCR Stock News

Omnicare Share News

 Omnicare Inc. Stock Price
OCR Stock Price
 Omnicare Inc. Stock Chart
OCR Stock Chart
 Omnicare Inc. Stock News
OCR Stock News
 Omnicare Inc. Company Information
OCR Company Information
 Omnicare Inc. Stock Trades
OCR Stock Trades

McKesson Taps Medical-Surgical Head To Lead US Drug Operations

DOW JONES NEWSWIRES McKesson Corp. (MCK) tapped Brian S. Tyler to lead its huge U.S. pharmaceutical business as the unit's current president, John Figueroa, prepares to leave for the top spot at nursing-home pharmacy services provider Omnicare Inc. (OCR). The transition comes as McKesson, the largest U.S. pharmaceuticals distributor by revenue, has seen slight revenue and margin growth of late. In October it reported its fiscal second-quarter profit rose 8.6% as revenue fell short of analysts' views. Its pharmaceutical-distribution business, which makes up the vast majority of its top line, saw revenue increase 1.3%. Tyler, a 13-year veteran of the company, has been leading McKesson's much smaller medical-surgical business. His successor has yet to be named. Figueroa had overseen the Omnicare account for roughly a dozen years while at McKesson. He takes the new role as Omnicare has struggled with a third-quarter loss, a slashed 2010 earnings forecast and the abrupt departure of longtime Chief Executive Joel Gemunder. McKesson shares closed Tuesday at $66.85 while Omnicare finished at $23.01. Neither was active premarket. -By Matt Jarzemsky, Dow Jones Newswires; 212-416-2240; matthew.jarzemsky@dowjones.com

Stock News for Omnicare (OCR)
DateTimeHeadline
08/25/201517:08:24Post-effective Amendment to an Automatic Shelf Registration of...
08/25/201517:01:32Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201517:01:07Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201517:00:40Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201517:00:14Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:59:47Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:59:47Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:59:22Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:59:22Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:58:53Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:58:53Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:58:00Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:57:36Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:57:35Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:57:08Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/20/201517:35:24Statement of Changes in Beneficial Ownership (4)
08/20/201517:34:24Statement of Changes in Beneficial Ownership (4)
08/20/201517:32:41Statement of Changes in Beneficial Ownership (4)
08/20/201517:31:49Statement of Changes in Beneficial Ownership (4)
08/20/201517:29:33Statement of Changes in Beneficial Ownership (4)

Omnicare and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad